Analysis of gene structure, cloning and expression of cyp51 from Ustilago maydis

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 24, Issue 10, 2008, Pages 1747-1753

  Han, Rui ^a   Deng, Lingfu ^a   Li, Chen ^a   Zhang, Qingye ^b   Zhang, Jie ^a   Gao, Qiang ^a   Xiong, Li ^a   Wan, Jian ^b   Liu, Deli ^a,b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Binding constant; Cloning and expression; Cyp51; Ustilago maydis

Indexed keywords

ESCHERICHIA COLI; FUNGI; USTILAGO MAYDIS;

ANTIFUNGAL AGENT; CYTOCHROME P450; FUNGAL PROTEIN; LANOSTEROL 14 ALPHA-DEMETHYLASE; RECOMBINANT PROTEIN; STEROL 14ALPHA DEMETHYLASE;

ARTICLE; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR CLONING; PLASMID; USTILAGO;

ANTIFUNGAL AGENTS; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; FUNGAL PROTEINS; PLASMIDS; RECOMBINANT PROTEINS; USTILAGO;

EID: 75349086499     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lepesheva GI, Waterman MR. CYP51-the omnipotent P450. Mol Cell Endocrinol, 2004, 215: 165-170.
2. Cao YB, Zhang L, Wang Y, et al. Voriconazole and its clinical use. Chin J New Drugs Clin Rein, 2005, 24: 330-332.
3. Martinez-espinoza AD, Garcia-pedrajas MD, Gold SE. The Ustilaginales as plant pests and model systems. Fungal Genet Biol, 2002, 35: 1-20.
4. Han LG, Yuan Y, Wang G. Extraction of DNA from filamentous fungal tissues. Biotechnol, 1999, 9: 38-41.
5. Gasteiger E, Hoogland C, Gattiker A, et al. Protein identification and analysis tools on the ExPASy server. The Proteomics Protocols Handbook, 2005, 571-607.
6. Krogh A, Larsson BR, Heijine GV, et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol, 2001, 305(3): 567-580.
7. Kall L, Krogh A, Sonnhammer EL. A combined transmembrane topology and signal peptide prediction method. J Mol Biol, 2004, 338(5): 1027-1036.
8. Podust LM, Poulos TL, Waterman MR, et al. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci, 2001, 98: 3068-3073.
9. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. J Biol Chem, 1964, 239(7): 2370-2378.
10. Guardiola-Diaz HM, Foster LA, Mushrush D, et al. Azoleantifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Biochem Pharmacol, 2001, 61(12): 1463-1470.
11. Schenkman JB, RemmerH, Estabrook RW. Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol, 1967, 3: 113-123.
12. Xiao M, Yang JY, Xiao WJ, et al. Application of binding spectra DMIs fungicide screening. Chin J Biotech, 2007, 23(6): 1129-1134.
13. Lamb DC, Kelly DE, Manning NJ, et al. Expression, purification, reconstitution and inhibition of Ustilago maydis sterol 14 alpha-demethylase (CYP51; P450 (14DM)). FEMS Microbiol Lett, 1998, 169: 369-373.